Rockefeller Capital Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
Rockefeller Capital Management's TWST Position: Q2 2026 in Review
Rockefeller Capital Management reduced its Twist Bioscience (TWST) stake by 3.8% in Q2 2026, selling an estimated $27.6K and leaving 10,829 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1643.
Rockefeller Capital Management first reported a position in TWST in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.9M in Q3 2021. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- Rockefeller Capital Management held 10,829 shares of Twist Bioscience worth $1.11M as of Q2 2026.
- Rockefeller Capital Management sold 424 Twist Bioscience shares in Q2 2026, an estimated $27.6K.
- Twist Bioscience made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1643 holding.
- Rockefeller Capital Management first reported a position in Twist Bioscience in Q4 2020 and has held it in 15 quarters since.
- Rockefeller Capital Management's Twist Bioscience position peaked at $1.9M in Q3 2021.
- 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.